Francesco Maura, Assistant Member at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored with his colleagues published in Blood:
“First new paper of the year.
Out on Blood Journal our collaborative effort aimed to decipher mechanisms of primary and acquired resistance to venetoclax in relapsed refractory multiple myeloma with t(11;14)(CCND1;IGH).
Lots of genomics and functional data.
Really grateful for this amazing collaborative effort with Mayo Clinic, University Hospital Ostrava, Emory University, Sylvester Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Lawrence Boise, Marcella Kaddoura, Leif Bergsagel, Vikas Gupta, Erin Wiedmeier-Nutor, Tomas Jalinek, Rafa Fonseca, Saad Z. Usmani, Shaji Kumar, and Linda Baughn.
Summary of the paper can be found on X.”
Title: Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).
Authors: Marcella Kaddoura, Julia Erin Wiedmeier-Nutor, Vikas A Gupta, Tomas Jelinek, Bachisio Ziccheddu, Suganti Shivaram, Hongwei Tang, Rebecca W Owens, Tereza Ševčíková, Rodrigo Fonseca, Michael A. Durante, Benjamin T. Diamond, Logan Zhao, Yuan Xiao Zhu, Chang-Xin Shi, Shannon M Matulis, Constantine S. Mitsiades, Carl Ola Landgren, Saad Z. Usmani, Roman Hajek, Marta Chesi, P. Leif Bergsagel, Esteban Braggio, Lawrence H Boise, Rafael Fonseca, Shaji K Kumar, Francesco Maura, and Linda B Baughn.
You can read the full article in Blood.
More posts featuring Francesco Maura.